ReP USP - Resultado da busca

Artigo de periodico
Effect of verapamil, an L-type calcium channel inhibitor, on Caveolin-3 expression in septic mouse hearts (2021)
Rattis, Bruna Amanda da Cruz; Freitas, Ana Caroline Silva de; Oliveira, Jordana F.; Calandrini-Lima, João L. A.; Figueiredo, Maria José; Soave, Danilo F.; Ramos, Simone Gusmão; Celes, Mara Rubia Nunes
Source: Oxidative Medicine and Cellular Longevity. Unidade: FMRP
Subjects: CANAIS DE CÁLCIO, SEPSE, ANÁLISE DE SOBREVIVÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RATTIS, Bruna Amanda da Cruz et al. Effect of verapamil, an L-type calcium channel inhibitor, on Caveolin-3 expression in septic mouse hearts. Oxidative Medicine and Cellular Longevity, v. 2021, p. 1-8, 2021Tradução . . Disponível em: https://doi.org/10.1155/2021/6667074. Acesso em: 11 nov. 2024.
APA
Rattis, B. A. da C., Freitas, A. C. S. de, Oliveira, J. F., Calandrini-Lima, J. L. A., Figueiredo, M. J., Soave, D. F., et al. (2021). Effect of verapamil, an L-type calcium channel inhibitor, on Caveolin-3 expression in septic mouse hearts. Oxidative Medicine and Cellular Longevity, 2021, 1-8. doi:10.1155/2021/6667074
NLM
Rattis BA da C, Freitas ACS de, Oliveira JF, Calandrini-Lima JLA, Figueiredo MJ, Soave DF, Ramos SG, Celes MRN. Effect of verapamil, an L-type calcium channel inhibitor, on Caveolin-3 expression in septic mouse hearts [Internet]. Oxidative Medicine and Cellular Longevity. 2021 ; 2021 1-8.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1155/2021/6667074
Vancouver
Rattis BA da C, Freitas ACS de, Oliveira JF, Calandrini-Lima JLA, Figueiredo MJ, Soave DF, Ramos SG, Celes MRN. Effect of verapamil, an L-type calcium channel inhibitor, on Caveolin-3 expression in septic mouse hearts [Internet]. Oxidative Medicine and Cellular Longevity. 2021 ; 2021 1-8.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1155/2021/6667074
Artigo de periodico
Curcumin as a Potential Treatment for COVID-19 (2021)
Rattis, Bruna Amanda da Cruz; Ramos, Simone Gusmão ; Celes, Mara Rubia Nunes
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: COVID-19, DOENÇAS INFECCIOSAS, AÇAFRÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RATTIS, Bruna Amanda da Cruz e RAMOS, Simone Gusmão e CELES, Mara Rubia Nunes. Curcumin as a Potential Treatment for COVID-19. Frontiers in Pharmacology, v. 12, p. 1-14, 2021Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.675287. Acesso em: 11 nov. 2024.
APA
Rattis, B. A. da C., Ramos, S. G., & Celes, M. R. N. (2021). Curcumin as a Potential Treatment for COVID-19. Frontiers in Pharmacology, 12, 1-14. doi:10.3389/fphar.2021.675287
NLM
Rattis BA da C, Ramos SG, Celes MRN. Curcumin as a Potential Treatment for COVID-19 [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-14.[citado 2024 nov. 11 ] Available from: https://doi.org/10.3389/fphar.2021.675287
Vancouver
Rattis BA da C, Ramos SG, Celes MRN. Curcumin as a Potential Treatment for COVID-19 [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-14.[citado 2024 nov. 11 ] Available from: https://doi.org/10.3389/fphar.2021.675287
Artigo de periodico
ACE2 down-regulation may act as a transient molecular disease causing RAAS dysregulation and tissue damage in the microcirculatory environment among COVID-19 patients (2021)
Ramos, Simone Gusmão; Rattis, Bruna Amanda da Cruz; Ottaviani, Giulia; Celes, Mara Rubia Nunes ; Dias, Eliane Pedra
Source: The American Journal of Pathology. Unidade: FMRP
Subjects: ANGIOTENSINA II, COVID-19, MICROCIRCULAÇÃO, SISTEMA RENINA-ANGIOTENSINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMOS, Simone Gusmão et al. ACE2 down-regulation may act as a transient molecular disease causing RAAS dysregulation and tissue damage in the microcirculatory environment among COVID-19 patients. The American Journal of Pathology, v. 191, n. 7, p. 1154-1164, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ajpath.2021.04.010. Acesso em: 11 nov. 2024.
APA
Ramos, S. G., Rattis, B. A. da C., Ottaviani, G., Celes, M. R. N., & Dias, E. P. (2021). ACE2 down-regulation may act as a transient molecular disease causing RAAS dysregulation and tissue damage in the microcirculatory environment among COVID-19 patients. The American Journal of Pathology, 191( 7), 1154-1164. doi:10.1016/j.ajpath.2021.04.010
NLM
Ramos SG, Rattis BA da C, Ottaviani G, Celes MRN, Dias EP. ACE2 down-regulation may act as a transient molecular disease causing RAAS dysregulation and tissue damage in the microcirculatory environment among COVID-19 patients [Internet]. The American Journal of Pathology. 2021 ; 191( 7): 1154-1164.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.ajpath.2021.04.010
Vancouver
Ramos SG, Rattis BA da C, Ottaviani G, Celes MRN, Dias EP. ACE2 down-regulation may act as a transient molecular disease causing RAAS dysregulation and tissue damage in the microcirculatory environment among COVID-19 patients [Internet]. The American Journal of Pathology. 2021 ; 191( 7): 1154-1164.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.ajpath.2021.04.010

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em